Rhythm Pharmaceuticals Inc
(STU:1RV)
€
39.255
-0.74 (-1.85%)
Market Cap: 2.43 Bil
Enterprise Value: 2.24 Bil
PE Ratio: 0
PB Ratio: 42.35
GF Score: 52/100 - Q1 2024 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024€40.05 (-0.76%)Earnings
- Q4 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2024€44.6Earnings
- Rhythm Pharmaceuticals Inc To Discuss On MC4R Pathway Programs Call TranscriptDec 06, 2023
- Q3 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2023€24 (-3.23%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Data Presentations Call TranscriptOct 18, 2023
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Rhythm Pharmaceuticals Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Q2 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2023€15.9Earnings
- Rhythm Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Rhythm Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2023€17.9 (+1.13%)Earnings
- Rhythm Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Q4 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2023€22.4Earnings
- Rhythm Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Q3 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022€22.4 (-1.75%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Hypothalamic Obesity Call TranscriptNov 02, 2022
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2022€11.8 (-0.84%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Hypothalamic Obesity Call TranscriptJul 12, 2022
- Rhythm Pharmaceuticals Inc To Discuss The FDA Approval Of IMCIVREE Call TranscriptJun 16, 2022
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Rhythm Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2022€5.65 (+0.89%)Earnings
- Q4 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022€6.65 (+1.53%)Earnings
- Rhythm Pharmaceuticals Inc To Host Virtual Bardet-Biedl Syndrome (BBS) Event Call TranscriptFeb 16, 2022
- Q3 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2021€10.1 (-0.98%)Earnings
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021€13.8 (-4.83%)Earnings
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 09, 2021
- Rhythm Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Rhythm Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptJan 26, 2021
- Rhythm Pharmaceuticals Inc Bardet-Biedl and Alstrom Syndromes Phase 3 Data Corporate Call TranscriptDec 22, 2020
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptNov 27, 2020
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 17, 2020
- Rhythm Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Rhythm Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptSep 25, 2019
- Rhythm Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptAug 07, 2019
- Rhythm Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptMar 28, 2019
Rhythm Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019 / 03:05PM GMT
Release Date Price:
€18.71
(-0.16%)
David Neil Lebowitz
Morgan Stanley, Research Division - VP
I'm one of the biotechnology analysts at Morgan Stanley, David Lebowitz. And I have with me on the stage from Rhythm Pharmaceuticals, CEO, Keith Gottesdiener. I'm sorry.
Keith Michael Gottesdiener
Rhythm Pharmaceuticals, Inc. - President, CEO & Director
No problem, no one ever uses my last name for exactly that reason.
David Neil Lebowitz
Morgan Stanley, Research Division - VP
I'll call you Keith G. Rhythm is a company that develops therapies for ultra-rare forms of genetic obesity. If you could, I guess, give us a top level just on the company and bring us up to speed on the recent updates.
Keith Michael Gottesdiener
Rhythm Pharmaceuticals, Inc. - President, CEO & Director
Sure. So Rhythm is a company, as David said, that focuses on rare genetic causes of obesity, and we are focused on the pathway in the brain called the melanocortin-4, MC4 pathway, which is probably the key pathway in the brain that
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)